中华耳鼻咽喉科杂志
中華耳鼻嚥喉科雜誌
중화이비인후과잡지
CHINESE JOURNAL OF OTORHINOLARYNGOLOGY
2001年
1期
58-60
,共3页
叶非常%魏骏%胡燕明%李显光%王胜军%梅桢峰%陈晓虹%汪银凤%徐瑞云
葉非常%魏駿%鬍燕明%李顯光%王勝軍%梅楨峰%陳曉虹%汪銀鳳%徐瑞雲
협비상%위준%호연명%리현광%왕성군%매정봉%진효홍%왕은봉%서서운
睡眠呼吸暂停综合征%治疗结果%多道睡眠描记术
睡眠呼吸暫停綜閤徵%治療結果%多道睡眠描記術
수면호흡잠정종합정%치료결과%다도수면묘기술
目的探讨用自行设计的咽通道管治疗阻塞性睡眠呼吸暂停综合征(obstructive sleep apnea syndrom, OSAS)的效果。方法利用咽通道管于1995年5月~1999年8月共治疗57例OSAS患者,治疗前后用国产GKD-405A六导睡眠监测呼吸暂停指数、低通气指数、呼吸紊乱指数、最长呼吸暂停时间、最低血氧饱和度、监测期间血氧饱和度大于90%时间的百分率和鼾声响度7项指标。结果治疗后最长呼吸暂停时间由(54.82±20.83)s降至(25.74±9.50)s,呼吸紊乱指数由70.82±18.06降至30.00±10.10,最低血氧氧饱和度由(62.36±11.53)%提高到(78.68±12.09)%,鼾声响度由(84.32±18.51)dB降至(32.64±10.16) dB,均较治疗前有明显改善(P<0.05~0.001,t值2.204~15.290)。掌握自行戴管技术的成功率为87.72%(50/57),长期置管率(半年以上)为72.73%(32/44)。结论本疗法对重症OSAS患者有明显疗效,可作为一种行之有效的非手术方法推荐。
目的探討用自行設計的嚥通道管治療阻塞性睡眠呼吸暫停綜閤徵(obstructive sleep apnea syndrom, OSAS)的效果。方法利用嚥通道管于1995年5月~1999年8月共治療57例OSAS患者,治療前後用國產GKD-405A六導睡眠鑑測呼吸暫停指數、低通氣指數、呼吸紊亂指數、最長呼吸暫停時間、最低血氧飽和度、鑑測期間血氧飽和度大于90%時間的百分率和鼾聲響度7項指標。結果治療後最長呼吸暫停時間由(54.82±20.83)s降至(25.74±9.50)s,呼吸紊亂指數由70.82±18.06降至30.00±10.10,最低血氧氧飽和度由(62.36±11.53)%提高到(78.68±12.09)%,鼾聲響度由(84.32±18.51)dB降至(32.64±10.16) dB,均較治療前有明顯改善(P<0.05~0.001,t值2.204~15.290)。掌握自行戴管技術的成功率為87.72%(50/57),長期置管率(半年以上)為72.73%(32/44)。結論本療法對重癥OSAS患者有明顯療效,可作為一種行之有效的非手術方法推薦。
목적탐토용자행설계적인통도관치료조새성수면호흡잠정종합정(obstructive sleep apnea syndrom, OSAS)적효과。방법이용인통도관우1995년5월~1999년8월공치료57례OSAS환자,치료전후용국산GKD-405A륙도수면감측호흡잠정지수、저통기지수、호흡문란지수、최장호흡잠정시간、최저혈양포화도、감측기간혈양포화도대우90%시간적백분솔화한성향도7항지표。결과치료후최장호흡잠정시간유(54.82±20.83)s강지(25.74±9.50)s,호흡문란지수유70.82±18.06강지30.00±10.10,최저혈양양포화도유(62.36±11.53)%제고도(78.68±12.09)%,한성향도유(84.32±18.51)dB강지(32.64±10.16) dB,균교치료전유명현개선(P<0.05~0.001,t치2.204~15.290)。장악자행대관기술적성공솔위87.72%(50/57),장기치관솔(반년이상)위72.73%(32/44)。결론본요법대중증OSAS환자유명현료효,가작위일충행지유효적비수술방법추천。
Objective To investigate the therapeutical effect of pharyngeal passage tube for OSAS. Methods Fifty-seven patients were treated during May 1995 to August 1999. All patients were examined by GKD-405 A polysomnography for apnea index (AI), hypnea index (HI), AHI (AI+HI) at cetera 7 items index before and after pharyngeal passage tube treatment. Results After treatment, the longest time of apnea shortened from (54.82±20.83) s to (25.74±9.50) s, the AHI lessened from 70.82±18.06 to 30.00±10.10, the oxygen desaturation increased from (62.36±11.53) % to (78.68±12.09)%. After treatment, the recorded parameters showed obvious therapeutical effect (P<0.05~0.001, t values is from 2.20 to 15.29, the snore loudness of all patients dropped from (84.32±18.51) dB to (32.64±10.16) dB. The therapeutical successful rate was 87.72%. The long-term use rate (over 6 months) was 72.73%. Conclusion The pharyngeal passage tube has obvious effect for patients suffering from severe OSAS. It is recommended for the treatment of OSAS as a concervative method.